MediciNova (NASDAQ:MNOV) investors are sitting on a loss of 89% if they invested five years ago

5d ago, source:

Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Imagine if you held MediciNova, ...

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

1mon ago, source: Stockhouse

LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...

MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in ...

1mon ago, source: The Bakersfield Californian

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...

MediciNova, Inc.

4mon ago, source: CNN

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company ...

MediciNova, Inc. (MNOV) interactive stock chart – Yahoo Finance

27d ago, source: Yahoo Finance

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange ...

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

1mon ago, source: Nasdaq

LA JOLLA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...

MediciNova, Inc. (MNOV)

9d ago, source: Yahoo Finance

LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan | Morningstar

1mon ago, source: Morningstar

Morningstar brands and products Company Get 7 Days Free ...

Medicinova Inc

13d ago, source: U.S. News & World Report

Semiconductor ETFs can help investors tap into tailwinds such as demand from artificial intelligence, government grants and a re-shoring movement.

MediciNova Inc.

4y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

MediciNova Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...